Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fred Callori currently holds 56,000 shares of Astria Therapeutics, Inc. (ATXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred Callori has been a net neutral trader of ATXS stock. They have purchased $0 and sold $0 worth of shares.
Fred Callori's most recent insider trade was on May 5, 2026, when they sold 56,000 shares at $0.00 per share.
Fred Callori serves as Executive at Astria Therapeutics, Inc. (ATXS). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Fred Callori holds the position of Executive at Astria Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Fred Callori has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Fred Callori was on May 5, 2026, when they purchased $0 worth of LONA shares. This transaction involved 56,000 shares at N/A per share.
Fred Callori currently owns 56,000 shares of Astria Therapeutics, Inc. (ATXS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fred Callori's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fred Callori has 5 Form 4 filings on record as an insider at Astria Therapeutics, Inc..
Set alerts for Fred Callori and 40,000+ other insiders.